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A C C E P T E D M A N U S C R I P T
for the first time the negative impact of chronification and exacerbation of headache attacks on the endogenous µ-opioid mechanisms of migraine patients. ClinicalTrials 
A C C E P T E D M A N U S C R I P T 1 Introduction
Migraine is a potentially progressive disorder, and in a given year, around 3% of individuals in the general population will develop chronic migraine (CMfrequent migraines and headaches on at least 15 days per month), while other 6% develop high frequency episodic headaches (10-14 days of headache per month) 1 . According to the American Migraine Prevalence and Prevention Study, 11.1% of episodic migraine (EM) and 34.3% of CM patients routinely use opioids 2, 3 . The number of migraine sufferers that use opioids can be as high as 72% in some in-patient clinics 4 .
In addition to excessive symptomatic medication use, thermal pain threshold (allodynia)
is also a risk factor for CM 5 , which makes the relationship between opioid use and CM complex, since opioids are potent inducers of hyperalgesia/allodynia 6 . Accordingly, opioid use, endogenous opioid release, and µ-opioid receptor (µOR) concentrations are critical elements for the understanding of general pathophysiology and worsening of pain in CM. So far, the only direct investigation of endogenous µ-opioid activation in vivo was done with positron emission tomography (PET) in EM patients with allodynia. This study showed a decrease in µOR non-displaceable binding potential (BP ND ) with [ 11 C]carfentanil 7 . µOR BP ND is a selective measurement of μOR availability in vivo, and its immediate decrease during EM headache attack (ictal phase) and allodynia mostly suggested the existence of a transitory increase in ictal activation of endogenous μ-opioid neurotransmission in the periaqueductal gray matter (PAG) and medial prefrontal cortex (mPFC), rather than a sharp change in the number of μOR 8, 9 .
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It is unknown, though, whether the chronification and severity of migraine attacks would have a significant negative effect on μOR availability in cognitive and emotional systems of the brain. Hence, to evaluate in vivo the dynamic of endogenous µ-opioid neurotransmission during CM attacks, we used PET molecular imaging to thoroughly investigate the impact of more severe forms of migraine and thermal pain threshold on the human endogenous μ-opioid system activity.
A C C E P T E D M
A N U S C R I P T ‖ Preventive medication was an exclusion criteria, and abortive medication was not allowed 48h prior the ictal PET scans. 
Standard protocol approvals, registrations and patient consents
The University of Michigan Institutional Review Board and the Radioactive Drug
Research Committee approved the study, and all participants provided written informed consent after the initial screening. ClinicalTrials.gov identifier: NCT03004313.
Response to cutaneous thermal stimulus (allodynia)
We applied a sustained thermal pain threshold (STPT) challenge, developed in-house, 9 with adjusted intensity to the trigeminal ophthalmic region (V1) of the participants during the late phase of the PET scan (ictally therefore). A light forehead system was used to hold a 16 mm 2 thermal probe (Pathway Model-MEDOC, Ramat Yishai, Israel), which was placed in contact with the forehead area (V1), ipsilateral to the headache. We applied the challenge for 20 min, which was appropriate to estimate μOR availability during a steady-state situation from 40 to 60 min post-radiotracer administration, and to collect enough data points for quantification. The temperature increased 1 o C/second every 10 seconds starting from a 32 o C baseline to a 50 o C maximum borderline. In this STPT
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model, the intensity of the temperature was controlled by tapping a mouse used for participants' feedback at every first perception of pain to instantly adjust the temperature back to baseline level.
Neuroimaging
We used PET for molecular neuroimaging in vivo to evaluate the endogenous μ-opioid response to the pain severity and the frequency of headache attacks in migraine at baseline (rest) and during ictal thermal pain threshold experience. Ninety minutes of PET scan per participant was sufficient to perform an early phase acquisition as a baseline (5-40 min) during headache (at rest), followed by the STPT challenge described above for 20 min in late phase (45-90 min) (thermal pain threshold response). Both phase acquisitions were performed in the same PET ictal session. Participant received PET and MRI images were aligned together before being warped to MNI-ICBM stereotaxic atlas space using a statistical parametric mapping (SPM8-v6313) package in Matlab (MathWorks, R2015b). Therefore, T1 images were co-registered with K1 images using a mutual information algorithm 15 . The transformation matrix was then applied to BP ND images. A non-linear warping algorithm DARTEL was then performed to standardize the anatomical MR images to MNI space. The transformation matrix was then applied to both BP ND and K1 ratio images 16, 17 . We smoothed the normalized and resampled BP ND images (2 mm voxels) with a 3-3-2 mm Gaussian Kernel to overcome the inter-subject variability of signal and improve the signal-to-noise ratio. Two patients'
images were flipped to have the thermal painful challenge (induced on the right or the left trigeminal ophthalmic side) on the same side of other images for all participants. Image
data were therefore presented as right-sided headaches for analysis, as the majority of patients have headaches on the right side.
Statistical analysis
Two-sample t-test, on a voxel-by-voxel basis 18 , was performed using SPM8 to examine differences in BP ND between the following groups: CM and HC, and CM and EM. Voxels with P value of less than 0.01 were considered to indicate a statistically significant difference as a first stage of group analysis in this study. We also performed a posteriori regions of interest analysis (ROIs) as a second stage of group analysis based on the amygdala, parahippocampal region, caudate, and thalamus, which are related to pain and opioidergic function, as identified in Zubieta et al. studies [19] [20] [21] [22] [23] . ROIs that were significant after cluster-level FWE correction (p<0.05) were extracted for further analysis using 
Clinical measures
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A C C E P T E D M A N U S C R I P T Table 3 . In multivariate analyses, acute activation of the endogenous μ-opioid neurotransmission interacting with μOR was highly correlated with type of the migraine (CM vs. EM), sensory-discriminative pain severity of the ongoing migraine attacks (P.A.I.N.S.: area vs. intensity), and allodynia (ictal thermal pain threshold) (overall R 2 =0.71) (Figure 2A ). Age and gender effects were not significant and were not included in the final model. Figure 2D ). The lower the cutaneous STPT, the more release of endogenous μ-opioid in the right amygdala.
Regions of Interest
A C C E P T E D M A N U S C R I P T 4 Discussion
Our findings show, for the first time in humans, that in CM patients during headache attack under cutaneous thermal pain challenge, there is significantly lower μOR BP ND in the thalamus and caudate compared to HC. Additionally, when compared to EM patients during spontaneous headache attacks with increased thermal pain sensitivity (allodynia), CM patients showed that this ictal μOR dysfunction extended to their limbic system, including the parahippocampal region and amygdala, which are highly correlated (71%).
Notably, in the right amygdala, such lower levels of μOR BP ND greatly correlated with the worsening of the headache attacks and, to some extent, the decrease in the ictal thermal pain threshold. As we noticed more significant changes in the limbic μOR BP ND in migraineurs only during the ictal thermal pain challenge, but not at ictal at-rest in the same PET session, the limbic dysfunction in CM implies an acute shift in receptor occupancy by endogenous opioids rather than a temporary change in the number of μORs. Hence, our data indicates that there is a significant increase in endogenous μopioid receptor-mediated neurotransmission in the human brain areas associated with negative emotional response during persistence and worsening of the ongoing attack and pain sensitivity (thermal allodynia) in CM (Figure 2 ).
The limbic system is responsible in great part for the processing of our emotional and motivational responses, decision-making, and memory consolidation. Migraine has been linked to memory disturbances and depression, especially with higher frequency of attacks 25, 26 , and is also associated with altered functional connectivity and structural plasticity in key limbic structures, including the parahippocampal area (e.g., enthorhinal cortex), hippocampus, and amygdala 27 . Neuroimaging studies of low and high frequency
A C C E P T E D M A N U S C R I P T migraine patients have reported morphometric changes in the enthorhinal cortex as one
the main distinguishers of CM 28 . This is a well-known limbic structure that modulates anxiety-driven hyperalgesia 29 , plays an important role in memory formation and consolidation, and is the main interface between the hippocampus and neocortex.
Hippocampal volume has also correlated negatively with the headache frequency in chronic migraineurs 27 . Such neuroplasticity in migraineurs seems to extend to other cortico-limbic regions associated with attack-related thermal pain threshold, and increased functional connectivity in the amygdala with other brain regions has been observed in CM compared to EM patients 30 .
The amygdala is well-known for its ability to activate arousal systems that affect information processing across the brain, triggering response-behavioral and neurophysiological changes that induce bottom-up attentional control over memory retrieval and sensory processing 31 . In fact, in rodent models with noxious stimuli, opioidergic dysfunction in the amygdala has been strongly connected to an increase in anxiety-like behaviors 32, 33 , especially when there is persistence of the pain inputs. Not surprisingly, recent studies have demonstrated an enhanced response to negative and aversive stimuli in migraine 34 . Furthermore, the involvement of the amygdala in chronic pain and migraine suffering might also be modulated by its lateralization of function 27 .
Nociceptive inputs equally reach both the left and right amygdala, but it is the right amygdala that plays a major role in the processing of nociceptive and emotional components of pain 35 When the CM patient is challenged with innocuous stimuli during the persistent attacks, the amygdala seems to contribute to sensitized avoidance-behavior neuromechanisms that help to protect the patient from interaction with the environment (e.g., exposure to heat, sound, light) until the headache subsides 18 .
The sensory process and modulatory neuromechanisms in repeated migraine attacks with thermal pain threshold have also been reported in CM animal and human models. In a rat model of CM induced by repeated meningeal infusion of inflammatory soup, there were notable changes in functional connectivity (FC) between PAG with PFC, thalamus, and
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other regions involved in nociception 37 . In humans, similar changes in FC where found in high frequent episodic migraineurs between PAG and PFC 38 . We previously demonstrated an increase in μ-opioid receptor-mediated neurotransmission in PAG and mPFC during a spontaneous EM attacks and allodynia 7, 8 , when compared to the interictal phase. Herein, when ictal CM attacks where compared with HCs during thermal challenge, we noticed that μ-opioid system activity was also increased in the thalamus and caudate, confirming that important brain regions generally involved in sensory processing and modulation of pain are also affected at the circuit level, facilitating ascending cephalic pain inputs with inefficient inhibitory pain modulatory responses to external stimuli 39, 40 Analysis section shows the magnitude of the effect size that the study can detect with sufficient (80%) power. In our data, the difference among the region identified had a A C C E P T E D M A N U S C R I P T large magnitude. We believe such findings will add to the literature, however, as is the case with many other studies, they need to be further investigated.
Conclusion
The weight of evidence from our current findings is that, overall, migraineurs have increased μ-opioid receptor-mediated neurotransmission in the pain perception and modulation brain regions during the attacks (Figure 3 ). However, with clinical chronification and aggravation of the attacks and increase in pain sensitivity (e.g., allodynia), which is largely the case in CM patients, dysfunctional μ-opioid activity escalates to the parahippocampal region as well as to the right amygdala. This flawed opioidergic activity in the limbic system provides the neuromechanistic explanation that likely contributes to the increased cognitive and emotional impact of pain on CM patients, enhanced global sensitivity to the environment evidenced by their thermal pain thresholds, and possibly their higher risk for medication overuse headache, and substance overuse, including opiates. Dr. Marcelo Bigal is the Chief Medical Officer for Purdue Pharma but has no conflict of interest with the study regarding financial support. His contribution was strictly scientific.
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